Prothrombotic and Proinflammatory Activities of the β-Hemolytic Group B Streptococcal Pigment.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Skorka, Sebastian B
Nijhuis, Roel H T
Pieper, Dietmar H
van den Bout, Christiaan J
Claas, Eric C J
Kuijper, Ed J
Wunderink, Herman F
MetadataShow full item record
AbstractA prominent feature of severe streptococcal infections is the profound inflammatory response that contributes to systemic toxicity. In sepsis the dysregulated host response involves both immunological and nonimmunological pathways. Here, we report a fatal case of an immunocompetent healthy female presenting with toxic shock and purpura fulminans caused by group B streptococcus (GBS; serotype III, CC19). The strain (LUMC16) was pigmented and hyperhemolytic. Stimulation of human primary cells with hyperhemolytic LUMC16 and STSS/NF-HH strains and pigment toxin resulted in a release of proinflammatory mediators, including tumor necrosis factor, interleukin (IL)-1β, and IL-6. In addition, LUMC16 induced blood clotting and showed factor XII activity on its surface, which was linked to the presence of the pigment. The expression of pigment was not linked to a mutation within the CovR/S region. In conclusion, our study shows that the hemolytic lipid toxin contributes to the ability of GBS to cause systemic hyperinflammation and interferes with the coagulation system.
CitationJ Innate Immun. 2019 Nov 19:1-13. doi: 10.1159/000504002.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
JournalJournal of Innate Immunity
The following license files are associated with this item:
- Creative Commons
- A Hyperhemolytic/Hyperpigmented Group B Streptococcus Strain with a CovR Mutation Isolated from an Adolescent Patient with Sore Throat.
- Authors: Whidbey C, Burnside K, Martinez RM, Gendrin C, Vornhagen J, Frando A, Harrell MI, McAdams R, Rajagopal L
- Issue date: 2015
- Phenotypic and molecular characterization of hyperpigmented group B Streptococci.
- Authors: Lupo A, Ruppen C, Hemphill A, Spellerberg B, Sendi P
- Issue date: 2014 Jul
- A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta.
- Authors: Whidbey C, Harrell MI, Burnside K, Ngo L, Becraft AK, Iyer LM, Aravind L, Hitti J, Adams Waldorf KM, Rajagopal L
- Issue date: 2013 Jun 3
- Mast cell degranulation by a hemolytic lipid toxin decreases GBS colonization and infection.
- Authors: Gendrin C, Vornhagen J, Ngo L, Whidbey C, Boldenow E, Santana-Ufret V, Clauson M, Burnside K, Galloway DP, Adams Waldorf KM, Piliponsky AM, Rajagopal L
- Issue date: 2015 Jul 17
- The genetically modified suilysin, rSLY(P353L), provides a candidate vaccine that suppresses proinflammatory response and reduces fatality following infection with Streptococcus suis.
- Authors: Du H, Huang W, Xie H, Ye C, Jing H, Ren Z, Xu J
- Issue date: 2013 Aug 28